-

STEMCELL Technologies Receives ISO 14001 Certification of Environmental Management System

Canadian-based biotech company adopts internationally recognized standards to enhance environmental performance

VANCOUVER, British Columbia--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, announced today that it has received ISO 14001:2015 certification of its Environmental Management System at its Canadian operations in Vancouver, BC.

STEMCELL’s now-certified Environmental Management System will enable the company to monitor, measure, analyze, and evaluate its environmental performance.

“As global citizens, all of us at STEMCELL understand we have an important role to play in addressing climate change and protecting the planet to help create a better, healthier future for everyone,” said Dr. Allen Eaves, STEMCELL’s President and CEO. “With this ISO 14001 certification, our customers and communities can have complete confidence that we are operating in accordance with best environmental management practices when creating and offering our best-in-class products and services for scientific research.”

The ISO 14001 certification—which applies to STEMCELL’s manufacturing, shipping, research and development, and head office facilities—is voluntary and confirms STEMCELL’s shared commitment to environmental stewardship through improving processes and procedures to reduce waste and lower carbon output.

The evaluation and audit of STEMCELL’s Environmental Management System was independently conducted by DEKRA, an internationally recognized authority that assesses environmental management systems for ISO 14001 certification.

“This achievement is only the beginning,” said Dr. Eaves.“We will build upon this momentum to go even further to embed sustainability practices into every aspect of our business and continue to improve our environmental performance now and into the future.”

More information about the International Organization for Standardization (ISO) can be found by visiting www.iso.org.

About STEMCELL Technologies

STEMCELL Technologies supports life sciences research with more than 2,500 specialized reagents, tools, and services. STEMCELL offers high-quality cell culture media, cell separation technologies, instruments, accessory products, educational resources, and contract assay services that are used by scientists performing stem cell, immunology, cancer, regenerative medicine, and cellular therapy research globally.

For more information and to arrange an interview, contact Kim Nelson, Director, Communications and Corporate Social Responsibility, STEMCELL Technologies: public.relations@stemcell.com

Contacts

Kim Nelson
public.relations@stemcell.com
Director, Communications and Corporate Social Responsibility
STEMCELL Technologies

STEMCELL Technologies


Release Summary
STEMCELL Technologies has received ISO 14001 Certification of its Environmental Management System.

Contacts

Kim Nelson
public.relations@stemcell.com
Director, Communications and Corporate Social Responsibility
STEMCELL Technologies

Social Media Profiles
More News From STEMCELL Technologies

STEMCELL Technologies and CCRM Partner to Expand Access to Matched GMP and RUO iPSC Lines for Cell Therapy Development

VANCOUVER, British Columbia & TORONTO--(BUSINESS WIRE)--STEMCELL Technologies and the Centre for Commercialization of Regenerative Medicine (CCRM) today announced a partnership to expand access to high-quality human induced pluripotent stem cell (iPSC) starting materials, giving cell therapy developers worldwide a faster, lower-risk path from research to the clinic. Under the agreement, STEMCELL will manufacture and distribute research-use-only (RUO) iPSC lines derived directly from LineaBio's...

STEMCELL Technologies Introduces STEMprep™ Tissue Dissociator System to Accelerate Research Discoveries

VANCOUVER, British Columbia--(BUSINESS WIRE)--To help scientists accelerate their workflows, STEMCELL Technologies has commercially launched the STEMprep™ Tissue Dissociator System—a new benchtop instrument that automates, standardizes, and streamlines tissue dissociation, the process of breaking down tissue samples into single-cell suspensions for research purposes. “Tissue dissociation is incredibly important for making advancements in research fields, like cancer and immunology, yet this man...

STEMCELL Technologies Announces Acquisition of Cellular Highways

VANCOUVER, British Columbia & CAMBRIDGE, England--(BUSINESS WIRE)--STEMCELL Technologies, Canada’s largest biotechnology company, is pleased to announce the acquisition of Cellular Highways Ltd from TTP Group Ltd. Cellular Highways is a biotechnology company based near Cambridge, United Kingdom, that specializes in advanced cell sorting technologies with applications in cell and gene therapy, drug discovery, and general cell research, especially where cells are fragile. The acquisition includes...
Back to Newsroom